kabutan

KAKEN PHARMACEUTICAL CO.,LTD.(4521) Summary

4521
TSE Prime
KAKEN PHARMACEUTICAL CO.,LTD.
3,765
JPY
-15
(-0.40%)
Dec 5, 3:14 pm JST
24.34
USD
Dec 5, 1:14 am EST
Result
PTS
outside of trading hours
3,766.5
Dec 5, 3:13 pm JST
Summary Chart Historical News Financial Result
PER
61.9
PBR
0.96
Yield
5.05%
Margin Trading Ratio
6.68
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
3,760 JPY 24.23 USD
Previous Close Dec 4
3,780 JPY 24.32 USD
High Dec 5, 10:18 am
3,780 JPY 24.39 USD
Low Dec 5, 9:05 am
3,750 JPY 24.16 USD
Volume
73,900
Trading Value
0.28B JPY 1.80M USD
VWAP
3767.13 JPY 24.36 USD
Minimum Trading Value
376,500 JPY 2,434 USD
Market Cap
0.17T JPY 1.08B USD
Number of Trades
213
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly High
1-Year Average
662
1-Year High Apr 9, 2025
2,521
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 35,200 90,300 2.57
Nov 21, 2025 41,300 120,800 2.92
Nov 14, 2025 49,700 162,800 3.28
Nov 7, 2025 24,000 127,800 5.33
Oct 31, 2025 25,500 127,000 4.98
Company Profile
KAKEN PHARMACEUTICAL CO.,LTD. is a mid-sized pharmaceutical company. Its main products include joint function improvement agents and onychomycosis medications. The company also develops generic drugs and agricultural chemicals.
Sector
Pharmaceuticals
KAKEN PHARMACEUTICAL CO.,LTD. primarily engages in the pharmaceutical business, manufacturing and selling pharmaceuticals, medical devices, and agricultural chemicals. The company operates as a group that includes itself and two consolidated subsidiaries. In the pharmaceutical segment, Kaken Pharma and Asam handle manufacturing and sales. Additionally, the company is involved in the real estate business. The group as a whole focuses on the medical field while diversifying into areas such as agriculture. As a mid-sized player in the pharmaceutical industry, KAKEN PHARMACEUTICAL CO.,LTD. has established a unique product lineup and business structure, with its main products including the joint function improvement agent "ARTZ" and the onychomycosis treatment "Clenafin."